)
Edge3 Apr 2026
Extra Everything: The Story of Chipotle
Chipotle's story from a single restaurant to a nationwide chain, through crisis and turnaround, built on one of the strongest models in the industry.
Syngene International
Syngene International (SYNGENE) investor relations material
Syngene International Q3 25/26 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 25/26 earnings summary23 Jan, 2026
Executive summary
Q3 revenue from operations declined 3% year-on-year to INR 917 crore, mainly due to ongoing impact from a single large molecule biologics product.
Nine-month revenue grew 3% year-on-year to INR 2,702 crore, with steady underlying business performance outside the impacted product.
Strategic 10-year extension of the Bristol-Myers Squibb partnership through 2035, supporting over 700 scientists and expanding integrated services.
Investments continued in scientific capabilities, manufacturing technologies, facility expansions, and new commercial-scale facilities for liquid-filled capsules.
Board approved unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025.
Financial highlights
Q3 operating EBITDA was INR 209 crore (23% margin), profit after tax before exceptional items at INR 73 crore; Q3 PAT margin at 7.8% (vs 13.6% in Q3 FY25).
Nine-month operating EBITDA was INR 615 crore (23% margin), profit after tax before exceptional items at INR 227 crore; 9M PAT margin at 8.2% (vs 10.9% in 9M FY25).
Q3 reported PAT was INR 15 crore, down 89% year-on-year, impacted by an exceptional item related to labor code changes.
Exceptional items in Q3 FY26 included a non-recurring expense of Rs. 706 million (consolidated) and Rs. 658 million (standalone) due to changes in labour laws.
Basic EPS (consolidated) for Q3 FY26 was Rs. 0.37, compared to Rs. 1.67 in the previous quarter and Rs. 3.27 in Q3 FY25.
Outlook and guidance
Full-year revenue expected to decline 3%-5% in constant currency, with operating EBITDA margin of 22%-23%.
CapEx for the year estimated at $45 million.
Impact from the single large molecule product expected to continue into FY 2027.
Continued investment in new technologies, AI, and advanced processes to drive future growth.
The company continues to monitor regulatory changes and will adjust compliance and accounting as new labour codes are finalized.
US biologics site acquisition: strategic impact?
Explain Labour Code impact on Q3 financials.
Bangalore facility: operational significance?
Quantify single product revenue impact in FY27
CDMO capacity utilization acceleration plan
New large client relationships and diversification
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Syngene International
- Q2 FY26 revenue up 2% YoY, but margins fell amid FX losses and global expansion.SYNGENE
Q2 25/2617 Mar 2026 - Q1 revenue fell 2% YoY, profit declined, but full-year guidance and margin outlook are steady.SYNGENEQ1 24/253 Feb 2026
- Q2 FY25 saw flat YoY results, 13% sequential growth, and recovery in discovery and biologics.SYNGENEQ2 24/2518 Jan 2026
- Q3 FY25 saw 11% revenue growth, margin gains, and strong biologics-driven performance.SYNGENEQ3 24/259 Jan 2026
- APAC and India accelerate clinical CRO growth with innovation, cost, and regulatory strengths.SYNGENEStatus Update17 Dec 2025
- Strong revenue growth, global expansion, and early-teens outlook for FY 2026 amid margin moderation.SYNGENEQ4 24/2529 Nov 2025
- Q1 FY26 saw strong revenue and profit growth, US site acquisition, and a Rs 1.25 dividend proposed.SYNGENEQ1 25/2620 Nov 2025
Next Syngene International earnings date
Q4 25/2624 Apr, 2026
Syngene International
Next Syngene International earnings date
Q4 25/2624 Apr, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage